Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183022 · ClinicalTrials.gov registry record · NA
Total30 Sphere Contact Lenses
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT05183022 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 48 participants.
The verdict
NCT05183022, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to map comfort over the full wear day in established, asymptomatic, soft CL wearers who are refit in Total30 Sphere CLs.
Interventions
- DEVICE Total30 Sphere Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05183022
The ClinicalTrials.gov registry entry for NCT05183022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Total30 Sphere Contact Lenses is the first listed.
NCT05183022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05183022 about?
NCT05183022 is a clinical study titled "Total30 Sphere Contact Lenses". The purpose of this study is to map comfort over the full wear day in established, asymptomatic, soft CL wearers who are refit in Total30 Sphere CLs.
What is the current status of trial NCT05183022?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2022-01-03. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT05183022?
The interventions under investigation include: Total30 Sphere Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT05183022?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.